Back
Tarsus Pharmaceuticals Stock Predictions

Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Sell
35
TARS
Tarsus Pharmaceuticals
Last Price:
$41.49
Seasonality Move:
-7.41%
7 Day Trial
ALL ACCESS PASS
$
7

Big exits started like this. So did Mode
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/eliteTarsus Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Tarsus Pharmaceuticals has on average historically risen by 21.5% based on the past 4 years of stock performance.
-
Tarsus Pharmaceuticals has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Tarsus Pharmaceuticals Stock Undervalued?The current Tarsus Pharmaceuticals [TARS] share price is $43.11. The Score for TARS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
TARS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Tarsus Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Tarsus Pharmaceuticals has on average historically risen by 21.5% based on the past 4 years of stock performance.
Tarsus Pharmaceuticals Stock Rating
Sell
35
Tarsus Pharmaceuticals (TARS)
is a Sell
Is Tarsus Pharmaceuticals overpriced?
-
Tarsus Pharmaceuticals has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Tarsus Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
tarsusrx.com
52-Week Data
52-Week High:
57.28
52-Week Low:
20.08
Prediction Charts
Market Cap:
1.8B
Price in USD:
43.11
Volume:
316K
Beta:
0.84
Technical Analysis
SMA50:
46.47
SMA100:
47.65
SMA200:
44.70
52-Wk Change:
33.88%
Stock Predictions
-
Is Tarsus Pharmaceuticals stock public?Yes, Tarsus Pharmaceuticals is a publicly traded company.
-
What is the Tarsus Pharmaceuticals stock quote today?The Tarsus Pharmaceuticals stock price is 43.11 USD today.
-
How to buy Tarsus Pharmaceuticals stock online?You can buy Tarsus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-20 | 44.93 | 44.88 | 45.18 | 44.59 |
May-21 | 44.88 | 43.19 | 45.48 | 43.06 |
May-22 | 43.00 | 42.97 | 43.73 | 42.59 |
May-23 | 42.90 | 42.98 | 43.23 | 42.47 |
May-27 | 43.87 | 41.88 | 43.99 | 41.70 |
May-28 | 41.79 | 42.05 | 42.84 | 41.01 |
May-29 | 42.19 | 43.44 | 43.47 | 41.50 |
May-30 | 43.52 | 42.95 | 43.52 | 42.04 |
Jun-2 | 43.45 | 43.85 | 44.32 | 42.47 |
Jun-3 | 43.89 | 43.91 | 44.41 | 43.48 |
Jun-4 | 44.20 | 42.65 | 44.52 | 42.57 |
Jun-5 | 41.53 | 44.08 | 44.26 | 40.28 |
Jun-6 | 44.33 | 43.92 | 45.35 | 43.45 |
Jun-9 | 44.74 | 43.11 | 44.79 | 43.09 |
Tarsus Pharmaceuticals Earnings
Tarsus Pharmaceuticals Earnings Report: Per Share Tarsus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Tarsus Pharmaceuticals Forecast Revenue Growth
Tarsus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Tarsus Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.65 per share, an increase next quarter of $0.74 per share, an increase this year of $1.85 per share, and an increase next year of $0.81 per share.
* Tarsus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.